Led · Series B · May 2023

Founded in 2014 by interventional cardiologist Dr. Charit Bhograj, Tricog Health builds multimodal AI models that interpret ECG and ultrasound signals to detect up to 140 cardiac conditions in real time. Its flagship solutions—InstaECG™, InstaEcho™, and the Keebo™ cardiovascular AI platform—are integrated into 12,500+ clinics and hospitals across more than 12 countries in Asia and Africa. To date, the company has screened over 31 million patients and identified about 1 million critical cardiac cases, making it one of the world’s most widely used cardiovascular AI systems. Tricog pairs its AI analytics with a team of more than 100 in-house clinical specialists to streamline diagnosis and activate standardized care pathways from hospital to home. The firm is collaborating with global device makers, including OMRON Healthcare, to expand remote monitoring and guideline-directed therapy optimization. Its stated goal is to make quality heart care accessible to 100 million people by 2030. No revenue or profitability figures were disclosed in the article.

Led · Series E · Nov 2020

AliveCor is a Mountain View, California-based provider of FDA-cleared personal electrocardiogram (ECG) technology solutions led by CEO Priya Abani. Its core consumer hardware includes the clinically validated KardiaMobile device and the multi-lead KardiaMobile 6L, which detects atrial fibrillation, bradycardia, tachycardia and various ECG rhythms. The company offers the Kardia AI-enabled platform to assist patients and clinicians in the efficient detection of atrial fibrillation. For enterprise customers AliveCor provides an enterprise platform including KardiaComplete for payors, employers, and health systems enabling front-end and back-end integration. AliveCor also operates a digital health subscription, KardiaCare, with more than 130,000 members offering advanced features to understand and manage heart health. The company intends to use new funding to expand its development efforts. AliveCor, based in Mountain View, CA and led by CEO Priya Abani, develops AI-based personal ECG technology and enterprise cardiology solutions. Its FDA-cleared KardiaMobile device is a clinically validated personal ECG that provides instant detection of atrial fibrillation, bradycardia, tachycardia, and normal heart rhythm. The company’s enterprise platform enables third-party providers to manage patients’ heart conditions with front-end and back-end integration to AliveCor technologies. To date, AliveCor’s products have served more than one million customers and recorded over 85 million ECGs. The company says it will use recent funding to accelerate growth of its remote cardiology platform domestically and around the world. Kardia aids patients and clinicians in the early detection of atrial fibrillation, a common arrhythmia associated with elevated stroke risk. AliveCor develops single- and six-lead smartphone ECG devices and AI-based interpretation software for consumer and point-of-care use. Its latest hardware, KardiaMobile 6L, launched in June and captures six perspectives by adding a third contact point. The company also secured FDA clearance for KardiaAI, an update for KardiaMobile and KardiaStation. AliveCor recently disclosed a new $5.78M infusion of capital and has a prior $30M round from 2017 led by Mayo Clinic and Omron Healthcare. Management has not announced how the new funds will be allocated. The business faces competition from entrants such as the Apple Watch’s ECG feature and has previously discontinued its KardiaBand for Apple Watch. AliveCor develops AI-enabled solutions to improve cardiac care, notably KardiaMobile and KardiaBand. KardiaMobile is an FDA-cleared product that instantly detects atrial fibrillation and normal sinus rhythm and is used worldwide for accurate ECG recordings. Paired with the Kardia app, KardiaMobile and KardiaBand provide instant analysis for detecting atrial fibrillation and normal sinus rhythm. Kardia is an AI-enabled platform for clinicians to manage patients for early detection of atrial fibrillation. The company said it will use new capital to support growth as well as research and development efforts. AliveCor is a Mountain View, California-based provider of FDA-cleared mobile electrocardiogram technology. Led by CEO Vic Gundotra, the company has launched Kardia Pro, an artificial intelligence-enabled platform that helps doctors monitor patients for early detection of atrial fibrillation. Kardia Pro tracks physiology measures such as weight, activity and blood pressure and creates a personal heart profile for each user, enabling user identification. AliveCor raised $30M in a Series D funding round led by Omron Healthcare, with participation from Mayo Clinic and existing inside investors. The company will use the capital to accelerate innovations in heart health and to continue expansion of the business. Its technology focuses on early detection of atrial fibrillation, the most common cardiac arrhythmia that increases stroke risk.

Participated · Equity · May 2020

D-ID is best known for Deep Nostalgia, which animates faces in old photos, and LiveStory, which adds audio narration to those animations. Its product mix includes consumer-facing projects (Deep Nostalgia, LiveStory and the upcoming Wishful mobile app) and developer-facing APIs used across media, education, marketing and enterprise customers. Deep Nostalgia has produced nearly 100 million animations, and D-ID’s MyHeritage collaboration helped the MyHeritage app amass roughly 42,300 reviews with a 4.8-star rating. The company has worked with partners including Warner Bros., Mondelēz, Publicis and Digitas Vietnam and has supported public-awareness campaigns for nonprofits and governments. D-ID is privately held and does not disclose revenue, but says it is growing quickly with many customers in the pipeline and expects significant growth this year. The 33-person company plans to scale sales and marketing in the U.S., APAC and EMEA and to double its deep-learning and computer vision teams while pursuing metaverse applications such as full-body 3D re-enactment. D-ID develops software that masks and blurs faces in photos and video to prevent identity cross-referencing. The company was founded by Gil Perry (CEO) alongside Sella Blondheim and Eliran Kuta, all veterans of the Israeli army’s unit 8200. Its core de-identification technology is being positioned as a privacy tool for governments and enterprises amid increased surveillance and new privacy legislation in Europe and some U.S. states. The same masking tools can also be applied to create deepfakes, and the company is exploring those applications. D-ID reports demand from automakers wanting to anonymize driver-monitoring systems and from security customers that want threat monitoring without storing identifying information. The company recently raised $13.5 million to support further development and commercialization. D-ID has built tools that block facial-recognition algorithms from "reading" photos and videos by introducing small, imperceptible changes that scramble what machines can detect while leaving images looking the same to the human eye. The company calls this approach "de-identification," aiming both to protect data already used for authentication and to prevent sensitive image data from ever being read. CEO and co-founder Gil Perry says the team will not disclose technical details but likens the approach to methods that confuse machine sensors while remaining imperceptible to humans. A pilot of the service is set to begin soon and a version of the product is scheduled to ship in May. The founding team — Perry, COO Sella Blondheim, and CTO Eliran Kuta — are ex-Israeli special forces with experience in AI algorithms and security identification services. D-ID closed a $4 million seed round to help bring its services to market.